Bottom Line, Up Front

We believe in a future where high-precision simulations are at the forefront of drug development and personalized medicine. Artificial intelligence will help us realize this goal.

In a simulation, the potential is limitless. Interactions between compounds and the cell can be predicted quickly and inexpensively, allowing us to alleviate the burden of time on drug discovery and bring new life to the fight against rare diseases. Our simulation will facilitate discovery-based research, meaning you don't need to know exactly what you're looking for – but we can help you find it.  

Better Cell Modeling Better Therapies Healthier People

Where We
Are Now

Peroxisomal disorders

Our immediate efforts are focusing on the peroxisome, an organelle linked to a class of orphan diseases called peroxisomal disorders. Peroxisomes have also been implicated in the pathogenesis of other diseases, such as cancer and neurological disorders, but there are currently no available treatments targeting these dysfunctional peroxisomes. 

Personalized, Whole-Cell Simulations

Imagine the ability to look inside your own cells and identify mutated organelles, predict protein-drug interactions, or simulate how your cell will age over time. Our simulation will allow for personalized cells to be built from an individual's genomic information.

Where We
Are Headed

Our Approach

A continually evolving pipeline to match a continually evolving scientific landscape

Laptop Keyboard

Artificial Intelligence

Our algorithms comb through scientific literature to select new disease targets. 

Image by Louis Reed

Docking Screen

After target identification, a virtual docking screen narrows down the set of potential new targets.  

Image by National Cancer Institute

Cell Simulation

Our simulated cell model allows for the further investigation of drug-target interactions. 


Phone: + 1 (617) 320-5379